Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded
- Contract number
- SPE2DB25FLWAF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,286
Award facts
- Contract value 100% obligated
- $26,285.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,285.85 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ultomiris (peginтerferon alfa-2b) 1,100 mg/11 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As the prime contractor on this award and the larger IDC, the company has demonstrated capability to meet federal procurement requirements through open competition and consistently delivers across a comprehensive portfolio of medical products including specialty medications, brand-name and generic drugs, and medical supplies. The DLA's broader Pharmaceutical Prime Vendor Global Program Generation V initiative plans to establish multiple regional contracts with separate contractors, positioning AmerisourceBergen among the key vendors supporting the department's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FLWAF?
SPE2DB25FLWAF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FLWAF worth?
The government has obligated $26,286 on SPE2DB25FLWAF.
Is contract SPE2DB25FLWAF an order under another contract?
Yes. SPE2DB25FLWAF is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLWAF competed?
The extent of competition for SPE2DB25FLWAF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award